Wansun Kim Selected Research

malachite green

1/2017	Low-Cost Label-Free Biosensing Bimetallic Cellulose Strip with SILAR-Synthesized Silver Core-Gold Shell Nanoparticle Structures.
12/2015	Facile Fabrication of a Silver Nanoparticle Immersed, Surface-Enhanced Raman Scattering Imposed Paper Platform through Successive Ionic Layer Absorption and Reaction for On-Site Bioassays.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wansun Kim Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2017
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2022
1	Keratoconjunctivitis 05/2022
1	Fatigue 03/2021
1	Stress Fractures (Stress Fracture) 04/2019
1	Myopia 01/2019
1	Hydrocephalus (Hydrocephaly) 07/2018
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 07/2018
1	Intracranial Vasospasm 07/2018
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Eye Diseases (Eye Disease) 01/2016
1	Carcinogenesis 12/2015
1	Papillomavirus Infections 12/2015
1	Infections 12/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2015

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2018
2	GoldIBA 07/2018 - 01/2016
2	malachite greenIBA 01/2017 - 12/2015
2	Silar (3M) (Silan)IBA 01/2016 - 12/2015
1	AdiponectinIBA 10/2022
1	ChAdOx1 nCoV-19IBA 05/2022
1	VaccinesIBA 05/2022
1	phenylalanine amideIBA 01/2021
1	AmidesIBA 01/2021
1	LipidsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	PolymersIBA 04/2019
1	CollagenIBA 01/2019
1	CarbohydratesIBA 01/2019
1	CelluloseIBA 07/2018
1	aniline (aniline hydrobromide)IBA 01/2017
1	Sodium AzideIBA 01/2017
1	Antiparasitic Agents (Antiparasitics)IBA 12/2015
1	SolutionsIBA 12/2015

Therapy/Procedure

1	Electrodes (Electrode) 03/2021